Headline

The latest stories from AHA Today.

CMS has delayed system edits that would require hospitals and health systems with multiple locations to include on outpatient prospective payment system claims for services provided in off-campus provider-based departments the exact same provider address entered in the Medicare Provider, Enrollment…
The Department of Health and Human Services has agreed to delay implementing its final rule concerning certain statutory conscience rights in health care, San Francisco City Attorney Dennis Herrera announced Friday.
Hospitals and health systems may apply through Aug. 27 for a portion of $3 million in funding to create Pediatric Disaster Care Centers of Excellence to enhance pediatric care during public health crises.
The Centers for Medicare & Medicaid Services Friday released a report on the final estimated results of the permanent risk-adjustment program for the 2018 benefit year.
The Centers for Medicare & Medicaid Services last week approved Section 1115 waivers allowing Minnesota and Nebraska to implement demonstration projects to increase access and treatment for Medicaid beneficiaries with opioid and other substance use disorders.
Medtronic has recalled certain MiniMed insulin pumps due to cybersecurity risks, and will provide alternative pumps to the estimated 4,000 U.S. patients using the pumps, the Food and Drug Administration announced yesterday.
The Centers for Medicare & Medicaid Services’ proposed guidance for hospital co-location with other hospitals or health care facilities “represents an important update to existing CMS policy,” AHA said today.
Fewer than 40% of the U.S. population has been tested for HIV, the Centers for Disease Control and Prevention reported yesterday, although the agency recommends everyone aged 13-64 get tested at least once.
The AHA's American Organization for Nursing Leadership is accepting abstracts through Aug. 2 for its 2020 conference March 18-21 in Nashville, Tenn.
The Senate Judiciary Committee today passed four bills aimed at lowering prescription drug costs and increasing competition.